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Summary 23 
Papillomaviruses appear to be species-specific pathogens, and it was suggested, that each 24 
animal species might harbour its own set of papillomaviruses. However all approaches 25 
addressing the underlying evolutionary phenomena suffer still from very limited data about 26 
animal papillomaviruses. In case of the horse for example only three equine papillomaviruses 27 
(EcPVs) have been identified. To further address the situation in this host, supposedly 28 
papillomavirus associated lesions were tested for EcPV DNA. Four novel EcPV types were 29 
detected and their genomes entirely cloned and sequenced. They display the characteristic 30 
organization with early (E) and late (L) regions harbouring the seven classical open reading 31 
frames divided by non coding regions. They were named EcPVs 4, 5, 6 and 7, according to 32 
their dissimilarity to other papillomaviruses. Most L1 nucleotide identities were shared with 33 
EcPV2 in case of EcPV4 (62%) and EcPV5 (60%) or with EcPV3 in case of EcPV6 (70%) 34 
and EcPV7 (71%). Thus, EcPVs 4 and 5 may establish novel species within the genus 35 
Dyoiota, while EcPVs 6 and 7 might fit into the Dyorho genus and belong to the same species 36 
as EcPV3. They were found in genital plaques (EcPV4) aural plaques (EcPV5, EcPV6) or 37 
penile masses (EcPV7). Interestingly PCR analysis revealed the DNA of EcPV2 and EcPV4 38 
as well as of EcPV3 and EcPV6 together in the same tissue samples, respectively. In 39 
conclusion the DNA of four novel EcPV types was identified and cloned. They cluster with 40 
the known types and support broad genetic EcPV diversity in at least two of the known 41 
clades. Furthermore, PCR assays also provide evidence for EcPV co-infections in horses. 42 
43 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Introduction 43 
The Papillomaviridae family, which has been established as an independent one separated 44 
from the Polyomaviridae twelve years ago, is rapidly growing, as new putative members are 45 
frequently discovered. Their members, the Papillomaviruses (PVs) have a characteristic 46 
circular double stranded DNA genome of around 8 kilobase pairs, that usually contains at 47 
least six relatively conserved open reading frames in an early (E1, E2, E6, E7) and a late (L1, 48 
L2) region. The DNA of the PVs is contained in icosahedral capsids mainly composed of 72 49 
L1 pentamers with a total diameter of approximately 50nm (Howley & Lowy, 2007). The 50 
Papillomaviridae family is considered as evolutionary very old, as there is a very high genetic 51 
diversity among PVs and several animal species have been shown to harbor their own set of 52 
PV types. The diversity is revealed in phylogenetic analyses and by 2010 almost 200 PV types 53 
had been recognized (Bernard et al., 2010). Almost two thirds of these so far known PV types 54 
infect humans, but the number of animal PV discoveries is increasing. The suspected 55 
overrepresentation of human PVs in many analyses regarding the phylogeny of PVs has led to 56 
different models that are somewhat contradictory (Rector et al., 2007; Bravo et al., 2010). The 57 
main obstacle in finding solid ground for a broadly acceptable hypothesis about PV evolution 58 
is a very poor resolution outside the human PV genera Alpha, Beta and Gamma. 59 
To classify novel PVs, the DNA sequence of the relatively conserved L1 open reading frame 60 
(ORF) is compared with the known ones and accordingly assigned to a genus and species as 61 
being a new type, subtype or variant. The criteria for this assignment define genus distinction 62 
below 60% identities and species distinction below 70% identities. Novel types have to differ 63 
by at least 10% and subtypes by no less than 2%, while smaller differences characterize 64 
variants (de Villiers et al., 2004; Bernard et al., 2010). Although this classification does not 65 
take into account putative evolutionally differences of the different PV genes or clinical 66 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aspects of PV infections it establishes a viable taxonomic system (de Villiers et al., 2004; 67 
Gottschling et al., 2011). 68 
The effects and the impact of PV infections on individuals as well as on public health in 69 
general have been partly uncovered in the past decade, with human PVs (HPVs) being in the 70 
focus of most efforts. HPVs have been demonstrated to contribute to various benign as well 71 
malignant transformations of epithelial cells, while it was also discovered, that apparently 72 
subclinical infections are very frequent (zur Hausen 1996; Antonsson et al., 2000; Howley & 73 
Lowy, 2007). Far less is indeed known about PV infections and their effects on animals. Thus, 74 
the far best studied animal PV infections include those of domestic animals, which is partly 75 
reflected in the number of types known to infect those species, namely 14 in case of dogs, 12 76 
in cattle, 5 in horses (BPV1, BPV2, EcPV1, EcPV2, EcPV3), 3 in sheep and 2 in cats. In this 77 
context the horse has a rather prominent role. Although PVs are general regarded as species 78 
specific, horses can be infected not only by equine, but also by bovine PVs (BPVs) (Scott & 79 
Miller, 2003; Bogaert et al., 2008; Nasir & Campo, 2008). While the infections with BPV1 80 
and BPV2 in horses have been a focus of some research for quite a while, actual equine PVs 81 
(EcPVs) were not a big issue until a few years ago. Until now three EcPVs were described, 82 
sequenced and cloned in their entity. They all seem to be associated with distinct pathologies. 83 
EcPV1 has been isolated from “classical equine papillomas”, a typical benign neoplasia of 84 
young horses that is usually transient (O’Banion et al., 1986; Scott & Miller, 2003; Ghin et 85 
al., 2004; Postey et al., 2007). In genital neoplasias of benign and malignant character the 86 
DNA of EcPV2 has been found and also repeatedly been detected in the most recent years. 87 
The data suggest that EcPV2 DNA may indeed be involved in the development of these 88 
disorders, although EcPV2 can also be detected in some other equine tumors, in semen and on 89 
clinically unaffected skin (Scase et al., 2010; Knight et al., 2011a; Knight et al., 2011b; Lange 90 
et al., 2011a; Bogert et al., 2012; Kainzbauer et al., 2012; Sykora et al., 2012; Lange et al., in 91 
press). The third one, EcPV3 has been detected in equine aural plaques that had also 92 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previously been suggested to be PV associated (Fairley & Haines, 1994; Postey et al., 2007; 93 
Lange et al., 2011a). These three EcPV types do represent also three different PV genera, 94 
namely Zeta, Dyoiota and Dyorho. There is also strong evidence for the existence of a fourth 95 
EcPV that had been sequenced partially (Taniwaki et al., 2013). The lack of closely related 96 
PVs makes a profound phylogenetic allocation of these EcPVs difficult. To improve the 97 
knowledge regarding PV phylogeny, to challenge the hypothesis that EcPVs may potentially 98 
be as diverse as bovine, canine and maybe human PVs and to find out more about potential 99 
involvements in the development of skin disorders this study was initiated.  100 
 101 
Results 102 
PCR and RCA Analysis 103 
One of the easiest and most sensitive methods to determine a putative PV association with any 104 
type of lesion is classical PCR. Three PCR assays for PV DNA and one for host DNA were 105 
therefore applied in all cases included. Host DNA was amplified in all the samples taken 106 
(Table 1). In cases #1 (vulval plaques) and #2 (penile and inguinal plaques), DNA was 107 
amplified with the FAP59/FAP64 and with the EcPV2probe f/r assays, sequencing revealed 108 
EcPV2 DNA as well as the DNA of a thus far unknown PV type. FAP59/FAP64 PCR 109 
revealed a different yet also previously not described PV DNA in case #3 (aural plaques). In 110 
the samples obtained from case #4 (aural plaques), CP4/CP5 PCR amplified EcPV3 DNA 111 
from one ear and a different undetermined PV DNA from the other, while it amplified EcPV3 112 
DNA in both with the WeF03/WeR09 PCR. CP4/CP5 PCR also amplified a novel PV DNA in 113 
the samples from case #5 (penile masses). No indication for the presence of HPV DNA was 114 
found in any of the cases. Samples containing unknown PV DNA were additionally tested 115 
using RCA. The RCA analysis indicated circular DNA of about eight thousand nucleotides in 116 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all these tested samples, whereas the restriction analysis of the RCA products produced 117 
patterns unlike any known EcPVs or BPVs. To determine the sequences in detail they were 118 
cloned and sequenced. The nucleotide sequences were deposited in GenBank under accession 119 
nos. JQ031032 (EcPV4), JQ031033 (EcPV5), JQ965698 (EcPV6) and JX035935 (EcPV7). 120 
 121 
Genomes and Open Reading Frames 122 
The genomes of PVs contain usually around 8 kilobasepairs (kbp) and have a genomic 123 
organization that typically displays seven or eight open reading frames (ORFs) as well as one 124 
or two non-coding-regions (NCRs) (Howley & Lowy, 2007). The genome sizes of the four 125 
cloned novel EcPVs were found to be very similar. The genome of EcPV4 consists of 7554 126 
basepairs, EcPV5 of 7519 basepairs, EcPV6 of 7551 basepairs and EcPV7 of 7619 basepairs. 127 
The GC contents are 55% for the EcPV4 genome, 50% for the EcPV5 genome, 51% for the 128 
EcPV6 genome and 52% for the EcPV7 genome. Seven characteristic ORFs were identified in 129 
all four novel EcPV genomes (Fig. 1). The ORFs encoding for the late PV genes appear to be 130 
quite conserved regarding their size. The greatest variation among the EcPVs was observed 131 
among the early genes E6 and E7. The E4 ORF, which usually lacks an own start codon 132 
varies between the viruses, and therefore can not be predicted with certainty. 133 
 134 
Characteristic motifs 135 
Several characteristic features on the nucleotide and amino acid level have been proposed and 136 
predicted to play a role in the PV life cycle (Androphy et al., 1987; Wilson et al., 2002; 137 
Münger et al., 2004; Howley & Lowy, 2007). The genomes of the four novel EcPV 138 
candidates were scanned to identify such putative sites and the analysis revealed typical 139 
features in of all of them (Table 2). Dyad symmetry repeats, a variable number of putative E2 140 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binding sites and at least one poly adenylation signal are present on every EcPV sequence. 141 
Sp1 and Nf1 binding sites could be predicted in all EcPVs, AP1 in all but EcPV4 and at least 142 
one classical TATA box in all but EcPV2 (Table 2(a)). Examination of the putative protein 143 
sequences revealed ATP-dependent helicase motifs in the E1 protein sequence of all EcPVs, 144 
but they were modified in the four novel ones. Putative metal-binding motifs were present in 145 
all E6 (2) and E7 (1) amino acid sequences. Leucine zipper domains were only found in the 146 
E1 of EcPV3 and EcPV7 as well as in the E2 of EcPV2 and EcPV4 (Table 2(b)). 147 
 148 
Sequence analysis and comparison 149 
To allocate the novel EcPVs, a phylogenetic analysis based on the aligned E1-E2-L2-L1 150 
sequences was performed. For that purpose the sequences of the eight different EcPV types or 151 
isolates as well as forty-two other PVs, representing all presently classified genera were 152 
aligned (Fig. 2). The EcPVs were found to cluster together with the Delta PVs with limited 153 
support of the branching by the posterior probabilities. The EcPV genera Zeta, Dyoiota and 154 
Dyorho were also allocated in relative vicinity of the Chi, Dyotheta and Iota PV genera in this 155 
analysis.   156 
For a putative taxonomic classification of the four novel PV isolates according to the present 157 
guidelines of PV classification (de Villiers et al., 2004; Bernard et al., 2010), pairwise 158 
alignments of the L1 nucleotide sequences were performed. EcPV4 was found to share most 159 
identities with EcPV5 (65%) and the two EcPV2 variants (62%). The L1 was also found to be 160 
match a partial PV sequence described before (Taniwaki et al., 2013). EcPV5 at the same time 161 
apparently shares more identities with EcPV2a (62%) than with EcPV2b (60%). EcPV6 and 162 
EcPV7 share most identities with each other (71%) and with EcPV3 (70%). All six obvious 163 
ORFs were analyzed in the same manner on the predicted amino acid level (Supplement 1). 164 
Over all the highest identities were among the sequences of EcPVs 3, 6 and 7, whereas EcPVs 165 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4 and 5 shared although closest to each other significantly less identities. The only exception 166 
was the E6 sequence. In case of E6 the identities between EcPVs 3, 6 and 7 were comparable 167 
to those between EcPVs 4 and 5. Consequently EcPV4 and EcPV5 may be regarded as 168 
representing two novel species within the genus Dyoiota, whereas EcPV6 and EcPV7 seem to 169 
belong to the same species as EcPV3 within the genus Dyorho. 170 
 171 
Discussion 172 
The number of known family members within the Papillomaviridae is constantly growing. 173 
However, while still more than half of the PVs described have been associated with human 174 
hosts more and more new discovered animal PVs are starting to alter our view on PV 175 
phylogeny and evolution. It appears that a lot if not all host species may harbor their own set 176 
of PV types that belong to a few distinct genera each. For the HPVs five such genera are 177 
currently recognized containing all of the more than 150 defined types and isolates (de 178 
Villiers et al., 2004; Bernard et al., 2010; Kovanda et al., 2011). Analogous to that the bovine 179 
and canine PV for example have been assigned to three genera each (Bernard et al., 2010). 180 
The same is true for the EcPVs. The here described four novel PV sequences support this 181 
hypothesis, as they cluster well together with the few known types within the three defined 182 
genera. Upon phylogenetic analysis the three EcPV genera cluster together with each other 183 
and with the Delta PVs. This is an interesting observation, as BPV1 and BPV2 that are 184 
although classified as bovine PVs also infect horses and cause disease belong to this genus. 185 
However, the statistic support for this clade formation is rather weak, and we probably still 186 
know only very few (too few) of the circulating animal PVs. Thus drawing conclusion from 187 
that would be probably be premature. Seeking for and sequencing further PV candidates may 188 
shed more light on these evolutionary and pathobiologically interesting issues.  189 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As the taxonomic classification of PVs is formally based on the L1 nucleotide sequence, the 190 
four novel EcPVs could easily be assigned to the relatively novel genera Dyoiota and Dyorho. 191 
Besides the genus they may be further classified into species within them. According to their 192 
L1 nucleotide sequences EcPV6 and EcPV7 may belong to the same species as EcPV3 within 193 
Dyorho. EcPV4 and EcPV5 however, although within Dyoiota like EcPV2 appear to represent 194 
two novel species within that genus. This is also supported by the pairwise comparison of the 195 
other individual ORFs, that except for E6, showed markedly more identities among the three 196 
Dyorho PVs than among the Dyoiota PVs (Supplement 1). The results of the phylogenetic 197 
analysis also point in the same direction. The definitive classification however is a matter of 198 
the ICTV and ICTV papillomavirus study group respectively. Interestingly there seems to be 199 
no correlation between genus and genome size among the EcPVs, whereas that seems to be 200 
the case with the HPVs (Alpha>Beta>Gamma), the BPVs (Delta>Epsilon>Xi) and the CPVs 201 
(Lambda>Tau>Chi) (Lange et al., 2009). 202 
Previous studies have shown that HPV DNA is not just very abundant on the skin of healthy 203 
individuals, but also, that the same host may be infected with or carry more than one PV type 204 
at the same time. The results of this study clearly indicate that this is the case in horses as 205 
well. In cases #1 and #2 EcPV2 DNA was detected in the same host and the same samples as 206 
the novel EcPV4 with different PCR assays. Similarly, in case four EcPV3 and EcPV6 DNA 207 
was detected in the same ear with two different the same PCR assays. Only a single double 208 
infection different PV types, namely with BPV1 and EcPV2 in a horse and supposedly double 209 
infections with different variants of EcPV2 had been described before (Kainzbauer et al., 210 
2012; Lange et al., in press). 211 
One of the most interesting and thus often very controversially discussed questions about PVs 212 
is their potential role in the pathogenesis of various neoplastic disorders. The four EcPVs 213 
described here have all been extracted from cytobrush samples of lesions that had been 214 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suspected to be PV associated, namely penile neoplasias, aural plaques and depigmented 215 
genital and inguinal plaques. Since no biopsy samples could be taken from any of these cases, 216 
it is not possible to determine whether any of the four new EcPVs actually played any role in 217 
the observed pathologies.  218 
In conclusion four novel EcPVs were discovered and genetically and phylogenetically 219 
analysed and characterized. The results support the clustering of EcPVs into the three 220 
established genera, confirm infections with more than one PV in horses and warrant further 221 
research regarding a possible pathogenicity and involved mechanisms. 222 
 223 
Materials and Methods 224 
Samples 225 
For this study, samples of 5 horses were obtained from patients of the veterinary teaching 226 
hospital of the Vetsuisse Faculty of the University of Zurich. Inclusion criteria were a 227 
suspected diagnosis of PV infection and PCR or RCA results indicating PV DNA of an 228 
unknown type. These included one Westfalian mare with white vulval plaques, a Friesian 229 
stallion with white inguinal plaques, an Arabian gelding with aural plaques, a German 230 
warmblood gelding with aural plaques and an Irish warmblood gelding with penile masses 231 
(Table 1). Testing material was acquired with cytobrushes that were moistened with sterile 232 
0.9% NaCl solution, gently rubbed for thirty seconds on putatively PV associated skin 233 
alterations and stored in an 1.5ml Eppendorf tube at -20°C until DNA extraction. 234 
 235 
Identification, Amplification and cloning of genomes 236 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DNA of the cytobrush samples was isolated using a DNeasy extraction kit (Qiagen). The 237 
protocol was slightly modified to meet the specific needs, namely the volume of all buffers 238 
used prior to the loading of the column was doubled to ensure the brush to be covered with 239 
liquid. The elution buffer was used sparsely (100µl in total) to increase the DNA 240 
concentration in the eluate. For initial identification of host and PV DNA in the samples 241 
ecGAPDH f (GAG CTG AAT GGG AAG CTC AC) / ecGAPDH r (CTG AGG GCC TTT 242 
CTC CTT CT), CP4/CP5, FAP59/FAP64, EcPV2probe f/r and WeF03 (TCT GGG TAG CCG 243 
CAA ATA TC) / WeR09 (GCA CCT GAG GTC CTA TCT GG) PCR assays were applied 244 
(Forslund et al., 1999; Iftner et al., 2003; Lange et al., in press). The protocols were applied as 245 
described, and in case of the ecGAPDH f/r and WeF03/WeR09 primers the same condition as 246 
for the EcPV2probe f/r were applied (Lange et al., 2011b; Lange et al., in press). PCR 247 
products were determined (Microsynth) by cycle sequencing using an ABI 377 sequencer 248 
(Applied Biosystems) and compared to the NCBI database (BLAST X). For the purpose of 249 
cloning one microliter of the DNA extract was used for rolling circle amplification (RCA) 250 
(Rector et al., 2004), using a TempliPhi Amplification kit (General Electrics Biosciences). 251 
Slight modifications were applied to the protocol supplied by the manufacturer (Lange et al., 252 
2009). Amplified PV DNA from cases #1 and #2 (EcPV4) was cloned into the BamHI, ClaI, 253 
EcoRI and HinDIII site of pBluescript II KS+ (Stratagene), into the HinDIII and XbaI sites in 254 
case of case #3 (EcPV5), into the BamHI site in case of case #4 (EcPV6) and the PV DNA 255 
amplified from case #5 was cloned into the BamHI and EcoRI sites (EcPV7) using standard 256 
procedures. The cloned DNA sequences of the PV candidates were determined (Microsynth) 257 
and primary sequences were assembled using Contigexpress software (Vector NTI Informax, 258 
Invitrogen). The names for viruses and genera were approved by the papillomavirus study 259 
group of the ICTV. 260 
 261 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Sequencing analysis 262 
The coding sequences for the E6, E7, E1, E2, L2 and L1 proteins of the four novel EcPVs 263 
were compared with previously published PV sequences including: Moose (Alces alces): 264 
AaPV1 (M15953), bovine (Bos primigenius): BPV1 (X02346), BPV3 (NC_004197), BPV5 265 
(AF457465), BPV7 (NC_007612), marine turtles: Caretta caretta: CcPV1 (EU493092) and 266 
Chelonia mydas: CmPV1 (EU493091), caprine (Capra hircus): ChPV1 (NC_008032), canine 267 
(Canis lupus familiaris): CPV1 (L22695), CPV2 (AY722648), CPV3 (NC_008297), CPV4 268 
(NC_010226), equine (Equus caballus): EcPV1 (AF498323), EcPV2a (NC_012123), EcPV2b 269 
(HM461973), EcPV3 (GU384895), porcupine (Erethizon dorsatum): EdPV1 (NC_006951), 270 
hedgehog (Erinaceus europaeus): EePV1 (EF396272), birds (Fringilla coelebs): FcPV1 271 
(NC_004068), Francolinus leucoscepus: FlPV1 (EU188799) and Psittacus erithacus: PePV1 272 
(NC_003973), feline (Felis catus):  FdPV1 (NC_004765), FdPV2 (EU796884), human 273 
(Homo sapiens): HPV1 (NC_001356), HPV4 (NC_001457), HPV5 (NC_001531), HPV9 274 
(NC_001596), HPV16 (FJ610146), HPV18 (NC_001357), HPV41 (NC_001354), HPV50 275 
(NC_001691), HPV63 (NC_001458), hamster: Mesocricetus auratus: MaPV1 (E15111), non-276 
human primate (Macacca mulata): MmPV1 (NC_001678), muridae (Micromys minutus): 277 
MmiPV1 (DQ269468) and (Mastomys natalensis): MnPV1 (NC_001605), snake (Morelia 278 
spilota): MsPV1 (HQ262535), rabbit (Oryctolagus cuniculus): OcPV1 (NC_002232), 279 
Porpoise (Phocoena spinipinnis): PsPV1 (NC_003348), fruit bat (Rousettus aeyptiacus): 280 
RaPV1 (NC_008298), cottontail rabbit (Sylvilagus floridanus): SfPV1 (NC_001541), porcine 281 
(Sus scrofa): SsPV1 (NC_011280), manatee (Trichechus manatus): TmPV1 (NC_006563), 282 
dolphin (Tursiops truncatus): TtPV1 (EU240894), TtPV2 (NC008184) and  polar bear (Ursus 283 
maritimus): UmPV1 (NC_010739). The predicted amino acid sequences were translated and 284 
aligned by using MAFFT (Katoh & Toh, 2008) before being back-translated to DNA 285 
sequences. The six sets of aligned nucleotide sequences representing the six sets of protein 286 
sequences were shortened by using GBLOCK (version 0.91b; 287 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http://molevol.cmima.csic.es/castresana/) (Castresana 2000) and combined to a single 288 
multiple sequence alignment (MSA) by concatenating the sequences from each virus. The 289 
optimal model of DNA evolution was evaluated for best fit of the data set using 290 
MODELTEST (version 1.4.4; http://darwin.uvigo.es/; default settings) (Posada & Crandall, 291 
1998). Bayesian phylogeny was inferred using MRBAYES (version 3.2; 292 
http://mrbayes.csit.fsu.edu/; Markov Chain Monte Carlo with GTR substitution matrix, 293 
variable gamma rates, invariant sites, two runs four chains of 10,000,000 generations), and 294 
displayed with FIGTREE (1.3.0 http://tree.bio.ed.ac.uk/) (Drumond & Rambaut, 2007). 295 
Pairwise sequence alignments were performed using NEEDLE (EMBOSS, nucleotide matrix: 296 
DNAFULL, amino acid matrix: BLOSSUM62). 297 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Figure legends 406 
Fig. 1 407 
Schematic genomes of equine papillomaviruses 408 
Schematic presentation of the seven equine papillomavirus genomes and their open reading 409 
frames (ORFs). Genomes are divided into sections: early genes (Early), late genes (Late) and 410 
non-coding regions (NCRs). Numbers indicate nucleotide positions. Nucleotide position 411 
number one is defined here as the first following the stop codon of the L1 ORFs. 412 
 413 
Fig. 2 414 
Phylogenetic tree of 50 papillomaviruses 415 
Midpoint rooted Bayesian phylogenetic tree of 50 papillomaviruses (PVs) representing most 416 
genera. Numbers at internal nodes represent the posterior probability support values. 417 
Unclassified PVs are marked with asterisks. Equine PVs are marked red. 418 
419 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Table 1: Included cases 419 
 420 
Case 
No. 
Gender Breed Age Symptoms Samples of results of PCR 
sequencing  
1 Mare Westfalian 6 White vulval 
plaques 
Plaque EcPV2, EcPV4 
Penis EcPV2 
Preputium EcPV2 
2 Gelding Frisian 10 White penile 
and inguinal 
plaques 
Inter inguinal EcPV2, EcPV4 
3 Gelding Arabian 5 Aural plaques Plaque EcPV5 
Left ear ‘s rim EcPV3 
Central left 
pinna 
EcPV3 
4 Gelding German 
warm blood 
8 Aural plaques 
left ear 
Central right 
pinna 
EcPV3, EcPV6 
5 Gelding Irish warm 
blood 
22 Penile masses Penile mass EcPV7 
 421 
422 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Table 2 422  Characteristic features on nucleotide and amino acid level 423   424 
(a) 425 
Predicted nt-feature 
 
EcPV1 EcPV2 EcPV3 EcPV4 EcPV5 EcPV6 EcPV7 
E2 binding site 
(ACC-N5-7-GGT) 
116; 3028, 
4168; 5298; 
5388; 6527; 
7144; 7378; 
7509 
 
318; 4828; 
5193; 7591; 
7760 
358; 650; 
1148; 4142; 
4226; 5001; 
6988; 7004; 
7124; 7218; 
7310; 7337: 
7468 
811; 1458; 
7133 
6971; 
7106; 
7150 
1643; 
4062; 
6986; 
7033; 
7245; 
7482 
4276; 
7001; 
7024; 
7047; 
7136; 
7243; 
7264; 
7513 
Dyad symmetry repeats 
(TTGTTGTTAACAACAA) 
7550  145  7510 7475 7453 7524 7555; 
3693 
Poly adanylation sites 
(AATAAA) 
2255; 3749; 
3756; 6882 
7216 2345; 6748; 
6808 
3937; 
6062; 
6944 
6928 2381; 
2444; 
5785; 
6397; 
6845 
2600; 
6273; 
6869 
Sp1 binding sites 
(GGCGGG) 
3815; 3997; 
4558; 5982; 
7357 
4707; 4929; 
5180; 6723; 
7788 
1915; 4272; 
4311; 4798; 
6967 
1077; 
2062; 
4949; 
5352; 
6168; 
7545 
1170; 
3310; 
3535; 
7282 
1207; 
3878; 
4848;  
41; 1196; 
3675; 
4585;  
Nf1 binding sites 
(CGGAA) 
483; 3329 2906; 3304; 
3421; 3575; 
3895; 5435 
361; 687; 
2946; 5591 
937; 1170; 
1764; 
1773; 
3035; 
3258; 
5531; 
5612; 
5883; 
6366; 
6890; 
7120; 
7310; 
7361; 
7412; 
7442 
2639; 
2698; 
2792; 
2987; 
6346; 
7254; 
7389;  
466; 1830; 
2139; 
2280; 
2737; 
5006; 
5977; 
6046; 
6175; 
6394; 
7059; 
7275;  
613; 1304; 
1791; 
1828; 
2143; 
2278; 
2707; 
2766; 
3940; 
4416; 
5997; 
6417; 
7130; 
7307; 
7351 
AP1 binding site 
(TGANTCA) 
3390; 4902 97 7459 - 7407 700; 7068; 
7197; 
7473 
683; 7187 
Tata signals 
(TATAAA or 
TATA(A/T)A(A/T)) 
6049; 6051; 
7600 
- 1563; 6547; 
6827 
5576 6376 276; 5488; 
6357; 
6946 
1597; 
6961 
 426 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(b) 427 
Predicted aa-
feature 
 
EcPV1 EcPV2 EcPV3 EcPV4 EcPV5 EcPV6 EcPV7 
ATP-dependent 
helicase motifs in 
E1 (GPPNTGKS) 
443aa/2016nt 455aa/2305nt 443aa/2028nt 453aa/2007nt 
T for S 
458aa/2031 
D for N 
438aa/2061nt 
D for N 
444aa/2061nt 
D for N 
metal-binding 
motifs in E6 
(CX2CX28-30CX2C) 
12aa/58nt; 
85aa/277nt 
8aa/260; 
83aa/485nt 
21aa/64nt; 
94aa/283nt 
10aa/58nt; 
84aa/280nt 
10aa/70nt; 
84aa/292nt 
19aa/114nt; 
92aa/331nt 
23aa/97nt; 
96aa/316nt 
metal-binding 
motifs in E7 
(CX2CX28-30CX2C) 
53aa/508nt 70aa/813nt 47aa/572nt 40aa/518nt 39aa/530nt 45aa/620nt 45aa/603nt 
Leucine zipper 
domain in E1 
(LX5-7 LX5-7 LX5-
7L) 
- - 264aa/1491nt - - 268aa/1552nt 273aa/1549nt 
Leucine zipper 
domain in E2 
(LX5-7 LX5-7 LX5-
7L) 
- 4aa/2777nt - 4aa/2479nt - - - 
 428 
 429 


